Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Myelodysplastic-Myeloproliferative Diseases × 3-aminopyridine-2-carboxaldehyde thiosemicarbazone × Clear all

Sponsor

Conditions

Uterine Cervical Neoplasms 3 Vaginal Neoplasms 2 Thrombocythemia, Essential 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Neuroendocrine Tumors 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Accelerated Phase 1 Gallbladder Neoplasms 1 Blast Crisis 1

Interventions

fludarabine phosphate 14 Cyclophosphamide 13 Peripheral Blood Stem Cell Transplantation 12 Whole-Body Irradiation 11 Busulfan 11 Mycophenolic Acid 10 Tacrolimus 9 Methotrexate 8 Cyclosporine 8 Antilymphocyte Serum 8 Etoposide 7 Melphalan 5 Cytarabine 5 Cyclosporins 5 Sirolimus 4 Radiotherapy 4 Rituximab 3 Filgrastim 3 Cord Blood Stem Cell Transplantation 3 thymoglobulin 2 ruxolitinib 2 Granulocyte Colony-Stimulating Factor 2 Flow Cytometry 2 Carmustine 2 Carboplatin 2 veliparib 1 vatalanib 1 treosulfan 1 sargramostim 1 rasburicase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡